Close Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$163K Sell
313
-50
-14% -$27.4K ﹤0.01% 125
2026
Q2
$191K Buy
363
+50
+16% +$28K 0.01% 126
2026
Q1
$176K Hold
313
– – ﹤0.01% 132
2025
Q4
$212K Hold
313
– – ﹤0.01% 130
2025
Q3
$200K Sell
313
-67
-18% -$40.7K ﹤0.01% 130
2025
Q2
$204K Sell
380
-30
-7% -$14.3K 0.01% 124
2025
Q1
$172K Hold
410
– – ﹤0.01% 123
2024
Q4
$170K Hold
410
– – ﹤0.01% 124
2024
Q3
$207K Hold
410
– – 0.01% 120
2024
Q2
$200K Hold
410
– – 0.01% 122
2024
Q1
$221K Hold
410
– – 0.01% 119
2023
Q4
$228K Buy
410
+30
+8% +$14.1K 0.01% 113
2023
Q3
$166K Buy
380
+300
+375% +$150K 0.01% 114
2023
Q2
$40K Buy
+80
New +$38.3K ﹤0.01% 165

Other funds holding IDXX

Close Asset Management's IDXX Position: Q3 2026 in Review

Close Asset Management reduced its Idexx Laboratories (IDXX) stake by 14% in Q3 2026, selling an estimated $27.4K and leaving 313 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #125.

Close Asset Management first reported a position in IDXX in Q2 2023 and has held it in 14 quarters since. The position peaked at $228K in Q4 2023. 1,280 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Close Asset Management held 313 shares of Idexx Laboratories worth $163K as of Q3 2026.
  • Close Asset Management sold 50 Idexx Laboratories shares in Q3 2026, an estimated $27.4K.
  • Idexx Laboratories made up ﹤0.01% of Close Asset Management's portfolio in Q3 2026, its #125 holding.
  • Close Asset Management first reported a position in Idexx Laboratories in Q2 2023 and has held it in 14 quarters since.
  • Close Asset Management's Idexx Laboratories position peaked at $228K in Q4 2023.
  • 1,280 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Close Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.